Sundial, Canopy Growth And More: Analyst Examines The Race For The US Cannabis Market
Canopy Growth, Aurora Cannabis, Cronos Group Leaving US CBD Market: Distressed Asset Opportunity?
Canopy Growth's Strategy To Deleverage Balance Sheet By $437M And Enhance Financial Flexibility
Acreage Holdings: Analyst Increases Price Target To $1.44 And Remains Neutral